Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform
Author(s) -
Juan Antonio GarcíaLeón,
Javier Vitórica,
Antonia Gutiérrez
Publication year - 2019
Publication title -
future medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.708
H-Index - 69
eISSN - 1756-8927
pISSN - 1756-8919
DOI - 10.4155/fmc-2018-0520
Subject(s) - induced pluripotent stem cell , drug discovery , disease , drug development , neuroscience , stem cell , drug , neural stem cell , transplantation , biology , computational biology , medicine , embryonic stem cell , bioinformatics , pharmacology , microbiology and biotechnology , pathology , biochemistry , surgery , gene
Most neurodegenerative diseases are characterized by a complex and mostly still unresolved pathology. This fact, together with the lack of reliable disease models, has precluded the development of effective therapies counteracting the disease progression. The advent of human pluripotent stem cells has revolutionized the field allowing the generation of disease-relevant neural cell types that can be used for disease modeling, drug screening and, possibly, cell transplantation purposes. In this Review, we discuss the applications of human pluripotent stem cells, the development of efficient protocols for the derivation of the different neural cells and their applicability for robust in vitro disease modeling and drug screening platforms for most common neurodegenerative conditions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom